acetylgalactosamine has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Ding, W; Li, S; Liu, J; Ma, L; Zhang, W | 1 |
| Dowdy, SF; Springer, AD | 1 |
1 review(s) available for acetylgalactosamine and Parkinson Disease
| Article | Year |
|---|---|
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.
Topics: Acetylgalactosamine; Asialoglycoprotein Receptor; Clinical Trials as Topic; Endocytosis; Endosomes; Gene Transfer Techniques; Glycoconjugates; Hepatocytes; Liver; Nanoparticles; Neoplasms; Parkinson Disease; RNA, Small Interfering; Virus Diseases | 2018 |
1 other study(ies) available for acetylgalactosamine and Parkinson Disease
| Article | Year |
|---|---|
Identification of ADP/ATP Translocase 1 as a Novel Glycoprotein and Its Association with Parkinson's Disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylgalactosamine; Adenine Nucleotide Translocator 1; Adenosine Diphosphate; Animals; Glycoproteins; Mice; Mitochondrial ADP, ATP Translocases; Parkinson Disease; Tandem Mass Spectrometry | 2022 |